The global Gaucher and Pompe diseases enzyme replacement therapy (ERT) market is projected to grow significantly, with its valuation expected to increase from USD 3.3 billion in 2023 to USD 6.2 billion by 2033. This robust growth, marked by a compound annual growth rate (CAGR) of 6.6%, underscores the rising demand for effective treatments for …